Biopharmaceuticals Global Business Report 2024 with Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
23 août 2024 07h20 HE
|
Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
2024 Microbiome Market Trends Report: Competitive Environment Analysis, Digital Platform and Marketing Strategies, and AI Adoption in the Industry
22 août 2024 10h56 HE
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. In the microbiome therapeutics market, some microbiome...
Human Microbiome Market Projected to Surpass to $3 Billion by 2032 with DuPont, Evelo Bio, Finch Therapeutics, Ginkgo Bioworks, Seres Therapeutics, AOBiome, Astarte Medical, Axial Biotherapeutics
14 août 2024 09h02 HE
|
Research and Markets
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market Report by Application Disease Product, Countries and Company Analysis, 2024-2032" report has been added to ...
Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership Techniques
07 août 2024 04h22 HE
|
Research and Markets
Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course" conference has been added to ResearchAndMarkets.com's...
Risk Management for Pharma and Biopharma Professionals: 1-Day Online Training Course (October 8, 2024) - Identify, Evaluate and Implement Specific Risk-based Techniques for Risk Management
06 août 2024 06h43 HE
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Risk Management for Pharma and Biopharma Professionals Training Course" conference has been added to ResearchAndMarkets.com's offering. Risk...
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies
17 juil. 2024 05h15 HE
|
BioProcess360
BioProcess360 Partners announce the launch of a new investment fund to support businesses with the growth of emerging bioprocessing technologies
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
11 juil. 2024 08h00 HE
|
Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
U.S. mRNA Synthesis Raw Materials (Capping Agents, Nucleotides, Plasmid DNA) Market Research 2024-2030: Growing Academic & Industrial Interest in MRNA Technology to Bolster Growth
10 juil. 2024 10h28 HE
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report, Type (Capping Agents, Nucleotides, Plasmid DNA), Application...
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
09 juil. 2024 02h00 HE
|
SciRhom GmbH
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary...
The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update): Anti-Obesity Medications Take Center Stage
03 juil. 2024 04h06 HE
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)" report has been added to ResearchAndMarkets.com's offering.Although the...